NCT04946539 - Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis | Crick | Crick

Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis

N/ACompletedNCT04946539

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization97 enrolled

Overview

The aim of the study is to determine how valuable ultrasonographic enthesitis to asssess disease activity, functionality and quality of life.

Study Type

OBSERVATIONAL

Enrollment

97

Conditions

Spondyloarthritis Enthesitis

Interventions

UltrasonographyDIAGNOSTIC_TEST

Enthesitis assessment via ultrasonography

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Spondyloarthritis patients that fulfill 2009 ASAS criteria Exclusion Criteria: * history of elbow, ankle or knee surgery, local injection at the examination sites within the six weeks, peripheral neuropathy, infection and wound at examination site

Outcomes

Primary Outcomes

Disease activity,

BASDAI (Bath Ankylosing Spondylitis Disease Activity Index), minimum value 0, maximum value 10, higher scores mean a worse outcome

Time frame: between November 2016 and January 2017

Disease activity,

Ankylosing Spondylitis Disease Activity Score (ASDAS). It is calculated by adding CRP (ASDAS-CRP) or ESR (ASDAS-ESR). there is no spesific minimal and maximum value because it depends on CRP or ESR value. Higher scores mean a worse outcome

Time frame: between November 2016 and January 2017

functionality

Bath Ankylosing Spondylitis Functionality Index (BASFI). Minimal values 0, maximum value 100. Higher scores mean a worse outcome

Time frame: between November 2016 and January 2017

to measure quality of life

Short Form - 12 (SF-12). minimum value 0 maximum value 100. higher scores mean a worse outcome

Time frame: between November 2016 and January 2017

to measure quality of life

Ankylosing Spondylitis Quality of Life (ASQoL). minimum value 0 maximum value 18. Higher scores mean a worse outcome

Time frame: between November 2016 and January 2017

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.